A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Cedars-Sinai-Developed ‘Healight' Medical Device Platform Technology Being Studied as a Potential First-in-Class COVID-19 Treatment Conference Call Scheduled for Tuesday, April 21, 2020 at 4:30 pm ET ENGLEWOOD, CO / April 20, 2020 / Aytu BioScience, Inc....
Chinese Officials Confirm China Won't Restrict Exports of Medical Products Needed to Fight Coronavirus Company in Late-Stage Negotiations to Secure Distribution Agreement for Additional COVID-19 IgG/IgM Rapid Test Which is Approved by China's National Medical Products...
Independent clinical study demonstrates test accuracy of 98.0% and 94.1% for IgG and IgM, respectively, when using PCR-positive cases as true positives ENGLEWOOD, CO / April 16, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), (the "Company"), a specialty pharmaceutical...
Company Places Third Purchase Order for One Million Tests ENGLEWOOD, CO / April 15, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs today provided an update...
ENGLEWOOD, CO / April 13, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today the launch of Regoxidine®, an over-the-counter foam...
ENGLEWOOD, CO / April 9, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced that, due to Colorado's "shelter in place" order related...
Aytu BioScience Licensee SUDA Pharmaceuticals Expands ZolpiMist Global Footprint Through Exclusive Licensing Agreement with Mitsubishi Tanabe Pharma Corporation ENGLEWOOD, CO / April 8, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty...
Cash and Cash Equivalents of Approximately $62.5 on March 31, 2020 ENGLEWOOD, CO / April 7, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs...
100,000 COVID-19 Rapid Tests Ready to Ship Across the Country with 500,000 More on the Way ENGLEWOOD, CO / April 6, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address...
First COVID-19 Rapid Tests Delivered to Denver First Responders ENGLEWOOD, CO / April 3, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs...